Association of FMO3 Variants and Trimethylamine N-Oxide Concentration, Disease Progression, and Mortality in CKD Patients.

by Cassianne Robinson-Cohen, Richard Newitt, Danny D Shen, Allan E Rettie, Bryan R Kestenbaum, Jonathan Himmelfarb, Catherine K Yeung
Published 2016-01-01

Potassium Measures and Their Associations with Glucose and Diabetes Risk: The Multi-Ethnic Study of Atherosclerosis (MESA).

by Ranee Chatterjee, Leila Zelnick, Kenneth J Mukamal, Jennifer A Nettleton, Bryan R Kestenbaum, David S Siscovick, Joachim H Ix, Russell Tracy, Andrew N Hoofnagle, Laura P Svetkey, David Edelman, Ian H de Boer
Published 2016-01-01

Vitamin D and Risk of Neuroimaging Abnormalities.

by Thomas J Littlejohns, Katarina Kos, William E Henley, Iain A Lang, Cedric Annweiler, Olivier Beauchet, Paulo H M Chaves, Bryan R Kestenbaum, Lewis H Kuller, Kenneth M Langa, Oscar L Lopez, David J Llewellyn
Published 2016-01-01

Soluble ST2 and Galectin-3 and Progression of CKD

by Mariam L. Alam, Ronit Katz, Keith A. Bellovich, Zeenat Y. Bhat, Frank C. Brosius, Ian H. de Boer, Crystal A. Gadegbeku, Debbie S. Gipson, Jennifer J. Hawkins, Jonathan Himmelfarb, Bryan R. Kestenbaum, Matthias Kretzler, Cassianne Robinson-Cohen, Susan P. Steigerwalt, Courtney Tuegel, Nisha Bansal
Published 2019-01-01

Comparison of host endothelial, epithelial and inflammatory response in ICU patients with and without COVID-19: a prospective observational cohort study

by Pavan K. Bhatraju, Eric D. Morrell, Leila Zelnick, Neha A. Sathe, Xin-Ya Chai, Sana S. Sakr, Sharon K. Sahi, Anthony Sader, Dawn M. Lum, Ted Liu, Neall Koetje, Ashley Garay, Elizabeth Barnes, Jonathan Lawson, Gail Cromer, Mary K. Bray, Sudhakar Pipavath, Bryan R. Kestenbaum, W. Conrad Liles, Susan L. Fink, T. Eoin West, Laura Evans, Carmen Mikacenic, Mark M. Wurfel
Published 2021-04-01